Search Articles
Lundbeck Inc. and Ovation Pharmaceuticals have a monopoly in Indocin and NeoProfen, for babies with a congenital heart defect, and use it to gouge prices, according to a federal class action in Minneapolis.
Categories /
Uncategorized
Subscribe to our free newsletters
Our weekly newsletter Closing Arguments offers the latest about ongoing trials, major litigation and rulings in courthouses around the U.S. and the world, while the monthly Under the Lights dishes the legal dirt from Hollywood, sports, Big Tech and the arts.